Exhaled Nitric Oxide and Airway Caliber in Children With Asthma

NCT01645397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2014-01-16

No results posted yet for this study

Summary

The purpose of this study is to assess if in steroid naïve asthmatic children with elevated baseline exhaled nitric oxide, treatment with inhaled steroid and normalization of exhaled nitric oxide level results in restoration of the bronchodilator response to deep inhalation.

Conditions

  • Asthma in Children

Sponsors & Collaborators

  • Atlantic Health System

    lead OTHER

Principal Investigators

  • Dagnachew Assefa, MD · Atlantic Health System

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-06-30
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645397 on ClinicalTrials.gov